title: [Evaluation of folate substitution in women with epilepsy. Determination of erythrocyte folic acid concentrations].
abstract: Insufficient maternal folate concentrations appear to be a fetal risk factor for neural tube defects (NTD). Erythrocyte folate concentrations are widely accepted as an indicator of tissue folate storage. We retrospectively evaluated erythrocyte folate concentrations to examine if a recommended daily dosage of 5 mg folic acid is sufficient to balance the impact of antiepileptic drugs (AED) on folate metabolism in women with epilepsy. Data of 48 women (mean age 30.3 years) with idiopathic epilepsy with generalized seizures (n=12) or symptomatic epilepsy with focal seizures (n=36) were available, 43 women submitted to further analysis and 30 women received AED monotherapy. Duration of folic acid supplementation varied between 0.5 and 12 months. The daily dosage of folic acid ranged from 0.4 to 15 mg and 32 women received 5 mg/day. Erythrocyte folate concentrations ranged from 282 to 1596 ng/ml (mean 780 ng/ml). In 29 out of the 32 women (90.6%) on 5 mg folic acid per day, red cell folate was ≥400 ng/ml. In previous studies the risk for NTD was estimated to be 0.8‰ if red cell folate was ≥400 ng/ml. Our results suggest that 5 mg/day folic acid as preconception supplementation in women with epilepsy is effective to balance the impact of AEDs on folate metabolism in women with epilepsy.
authors.affiliation: Klinik für Epileptologie, Universitätsklinikum Bonn, Sigmund-Freud-Straße 25, 53105, Bonn. juergen.bauer@ukb.uni-bonn.de
authors.forename: J
authors.initials: J
authors.lastname: Bauer
authors.forename: M
authors.initials: M
authors.lastname: Bös
authors.forename: J
authors.initials: J
authors.lastname: Rück
authors.forename: B
authors.initials: B
authors.lastname: Stoffel-Wagner
mesh_terms: D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004827:Epilepsy / Q000175:diagnosis / Q000188:drug therapy*; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D005494:Folic Acid Deficiency / Q000139:chemically induced* / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000927:Anticonvulsants; D005492:Folic Acid